s6y

BullFrog AI Holdings, Inc.

Ticker
BFRG, BFRGW
CIK
1829247
Industry
Pharmaceutical Preparations

Financials 18

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 18 financials filings

News 48

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 48 news filings

Ownership 48

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 48 ownership filings

Prospectus 26

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 26 prospectus filings

Proxies 6

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements

Other 60

  1. EFFECT Notice of Effectiveness
  2. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  3. UPLOAD Letter (PDF)
  4. EFFECT Notice of Effectiveness
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. UPLOAD Letter (PDF)
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. UPLOAD Letter (PDF)
  9. 144 Filing for proposed sale of securities under Rule 144
  10. SCHEDULE 13G/A

All 60 other filings